SCHEMBL6048567

SCHEMBL6048567

CN(C)Cc1ccccc1-c1ccc(F)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.50
SLC6A4 P31645 10/20 0.48
SLC6A2 P23975 6/20 0.48
SLC6A3 Q01959 6/20 0.48
CYP1A2 P05177 4/20 0.47
CYP3A4 P08684 4/20 0.47
CYP2D6 P10635 4/20 0.47
CLK4 Q9HAZ1 2/20 0.47
PTGS1 P23219 1/20 0.47
CYP2C19 P33261 2/20 0.45
ALDH1A1 P00352 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HTR2A P28223 1/20 0.43
F2 P00734 1/20 0.43
F10 P00742 1/20 0.43
KLK1 P06870 1/20 0.43
ITGB1 P05556 1/20 0.41
ITGA4 P13612 1/20 0.41
ITGB7 P26010 1/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6048542 0.98 PTGS2 (0.49) PTGS2SLC6A4SLC6A2SLC6A3CYP1A2
SCHEMBL6048560 0.86 SLC6A4 (0.58) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL6048497 0.86 SLC6A4 (0.54) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL6048489 0.84 SLC6A4 (0.52) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
Hydrochloric Acid SCHEMBL6048509 0.84 SLC6A4 (0.56) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL9289358 0.83 PTGS2 (0.57) PTGS2CYP1A2CYP3A4CYP2D6PTGS1
SCHEMBL27510002 0.80 PTGS2 (0.40) PTGS2SLC6A4SLC6A2SLC6A3CYP1A2
SCHEMBL6048563 0.80 SLC6A4 (0.54) PTGS2SLC6A4SLC6A2SLC6A3CYP1A2
SCHEMBL6048545 0.80 CYP1A2 (0.48) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL3465931 0.80 CYP2D6 (0.48) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202953-B1 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES GRUENENTHAL GMBH (DE) 2006-08-30 EP claimed
US-6710080-B2 ANALGESICS GRUENENTHAL GMBH (DE) 2004-03-23 US claimed
JP-2003506426-A 2003-02-18 JP claimed
US-20020198251-A1 Substituted 2-dialkylaminoalkylbiphenyl derivatives GRUENENTHAL GMBH (DE) 2002-12-26 US claimed
EP-1202953-A2 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES Grünenthal GmbH (DE) 2002-05-08 EP claimed
WO-2001010816-A2 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES Grünenthal GmbH (DE) 2001-02-15 WO claimed
EP-1202953-B1 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES GRUENENTHAL GMBH (DE) 2006-08-30 EP disclosed
US-6710080-B2 ANALGESICS GRUENENTHAL GMBH (DE) 2004-03-23 US disclosed
US-20020198251-A1 Substituted 2-dialkylaminoalkylbiphenyl derivatives GRUENENTHAL GMBH (DE) 2002-12-26 US disclosed
EP-1202953-A2 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES Grünenthal GmbH (DE) 2002-05-08 EP disclosed
WO-2001010816-A2 SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES Grünenthal GmbH (DE) 2001-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198251-A1 Substituted 2-dialkylaminoalkylbiphenyl derivatives LIPA, PKD1, PKD2 PTGS2 586/4885SLC6A4 1586/4885SLC6A2 1499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.